Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Terminated 1Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 3Lymphoid 2Tumor-Agnostic 1Sarcoma 1Other 1Gynecologic 1CNS 1

Conditions

Overweight 1Obesity 1Infertility 1Endometrial Neoplasms 1

Interventions

tegaserod 3naloxegol 3Radiotherapy 3Cisplatin 3Surveys and Questionnaires 2Radiation 2Lidocaine 2prucalopride 1pegfilgrastim 1oxycodone naloxone combination 1indole-3-carbinol 1hydrated silica gel-based toothpaste 1glucarpidase 1angiotensin I (1-7) 1alvimopan 1aluminum hydroxide, magnesium hydroxide, drug combination 1Vitamin D 1Transcutaneous Electric Nerve Stimulation 1Thyrotropin-Releasing Hormone 1Tablets 1Surgical Procedures, Operative 1Sennosides 1Selenomethionine 1Phenolphthalein 1Observation 1Nutrition Assessment 1Neck Dissection 1Methotrexate 1Methods 1Metformin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Tablets × Other × Clear all
NCT05316467 2026-06-04

Weight Management Plus Megestrol Acetate in Early-stage Endometrioid Carcinoma

Fudan University

Phase 2/3 Terminated
8 enrolled
GynecologicOther

Infertility, Obesity, Endometrial Neoplasms, Overweight

Data powered by HemOnc (CC BY 4.0) Colophon âš¡